ROR2 overexpression
|
Melanoma
|
ROR2 overexpression
|
Melanoma
|
paclitaxel Resistant: D – Preclinical
|
paclitaxel Resistant: D – Preclinical
|
ROR2 overexpression
|
Melanoma
|
ROR2 overexpression
|
Melanoma
|
FL118 Resistant: D – Preclinical
|
FL118 Resistant: D – Preclinical
|
ROR2 overexpression
|
Melanoma
|
ROR2 overexpression
|
Melanoma
|
lomustine Resistant: D – Preclinical
|
lomustine Resistant: D – Preclinical
|
ROR2 overexpression
|
Melanoma
|
ROR2 overexpression
|
Melanoma
|
dacarbazine Resistant: D – Preclinical
|
dacarbazine Resistant: D – Preclinical
|
ROR2 overexpression
|
Melanoma
|
ROR2 overexpression
|
Melanoma
|
cisplatin Resistant: D – Preclinical
|
cisplatin Resistant: D – Preclinical
|